Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)

NCT06195267 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT06195267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06195267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2024
Completion date
December 31, 2025
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aortic dissection, cardiovascular diseases (cvd), systemic inflammatory response syndrome